BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 226 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,853,000 | -48.5% | 45,333 | -50.4% | 0.00% | -40.0% |
| Q2 2022 | $13,312,000 | +35.9% | 91,363 | +10.6% | 0.01% | +66.7% |
| Q1 2022 | $9,794,000 | +33.6% | 82,599 | +55.3% | 0.00% | +50.0% |
| Q4 2021 | $7,330,000 | -28.9% | 53,186 | -28.3% | 0.00% | -33.3% |
| Q3 2021 | $10,303,000 | +538.0% | 74,176 | +346.0% | 0.00% | +200.0% |
| Q2 2021 | $1,615,000 | +42.2% | 16,633 | +0.0% | 0.00% | – |
| Q1 2021 | $1,136,000 | -50.8% | 16,625 | -38.3% | 0.00% | -100.0% |
| Q4 2020 | $2,311,000 | +20.1% | 26,960 | -8.9% | 0.00% | 0.0% |
| Q3 2020 | $1,925,000 | – | 29,608 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
| Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
| ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
| DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
| Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
| Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |